Hugh Auchincloss
Massachusetts General Hospital, McGill University, Harvard University
Papers
5
Total Citations
120
H-Index
5
About
Hugh Auchincloss is a leading thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for lung cancer, with a particular focus on robotic-assisted surgery and perioperative outcomes. His major contributions include leading the landmark COMPARE study (2024, 51 citations), a comprehensive analysis comparing 30-day outcomes across da Vinci robotic-assisted, laparoscopic/video-assisted, and open oncologic procedures, demonstrating the benefits of robotic surgery in complex, anatomically challenging cases. He has also pioneered innovative approaches to intraoperative drug sensitivity testing, as shown in his first-in-human study of multidrug-eluting microdevices implanted directly into non-small cell lung cancer tumors (7 citations). His research consistently evaluates healthcare resource utilization and value-based care, showing that minimally invasive approaches reduce hospital stays and costs without compromising oncologic outcomes. With additional work on ultrasonic energy sealing for pulmonary vessels and comparative outcomes for stage II-IIIA lung cancer, Auchincloss has established himself as a key voice in the evidence-based adoption of robotic thoracic surgery, directly influencing surgical practice and patient recovery pathways.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5